Since the establishment in 1941, Yuyu Pharma, Inc. as one of the leading pharmaceutical companies in Korea, has been manufacturing, marketing and distributing high quality pharmaceutical products not only in Korea but also exporting to many other countries including Malaysia, Vietnam, Philippines, Thailand, Pakistan and Syria.

Since its establishment of the Central Research Institute in 1989, Yuyu Pharma has developed Maxmarvil tab. the combined new drug for osteoporosis patented in USA, EU, Japan and China as well as in Korea, followed by Yuclid tablet, the combined new drug for anti-platelet patented in USA, EU, Japan and China as well as in Korea.

Yuyu Pharma, Inc. has many global networks with partnership as strategic alliances in USA(Nonin Medical/AirSep), Germany(Dr. Willmar Schwabe), UK(GSK), France(Lab de la Mer/Sanofi) and Japan(Meiji Seika/Taisho).

Furthermore, for business diversification, Yuyu Pharma has 4 subsidiaries including Yuyu Health Care for health foods, Yuyu Teijin Medicare for medical devices and International Scientific Standard for BE Test and its clinical studies and Yuyu Calmic for washroom Hygiene service plus formed a special team for cosmetics and medical equipments as well.